揭示了糖基化生物治疗药物的分子异质性
Luis F Schachner1, Christopher Mullen2, Wilson Phung1
1Department of Microchemistry, Proteomics and Lipidomics, Genentech, Inc., South San Francisco, CA, USA.
Nature communications
|April 16, 2024
概括
分析生物治疗异质性对于药物安全性和有效性至关重要. 使用质子转移电荷减小和气相分离的新质谱法在单个实验中准确地表征完整,异质和糖化蛋白质.
科学领域:
- 生物化学 生物化学
- 分析化学 分析化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 生物治疗药物表现出异质性,特别是由于糖化,影响安全性和有效性.
- 目前的分析方法很难描述完整的异质生物治疗方法.
- 对生物治疗异质性的准确描述对于药物开发和质量控制至关重要.
研究的目的:
- 开发和验证一种基于质谱学的新型方法,用于评估生物治疗中的分子异质性.
- 提供生物治疗制剂中完整分子重量的全面分析.
- 为了使糖化模式和蛋白质形式多样性的详细表征.
主要方法:
- 质子转移电荷减小与气相分化相结合.
- 高分辨率质谱仪用于完整的葡萄糖蛋白分析.
- 适用于各种生物治疗分子,包括Fc融合和VHH融合蛋白.
主要成果:
- 该方法在单个实验中成功分析了异质和糖化生物治疗药物的完整分子量.
- 对各种生物治疗分子进行了详细的蛋白质形式水平多样性测量.
- 葡萄糖形式分布被推断为一种高糖化药物 (IL22-Fc),将亚群与药理性质联系起来.
结论:
- 开发的方法为评估新兴生物治疗药物的分子异质性提供了一个强大的工具.
- 这种方法提供了关于糖组成和蛋白质形式多样性的关键见解.
- 该技术广泛适用于生物治疗特征和质量评估.
相关概念视频
Protein Glycosylation
6.9K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.9K
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Multiple Allele Traits
34.2K
The Concept of Multiple Allelism
34.2K


